ISRCTN13175485已完成1 期
A Phase Ia, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single-ascending doses of RO7303509 in healthy volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 57
研究概览
简要总结
2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38662148/ (added 26/04/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age =18 years and =75 years
- •2. Ability to comply with the study protocol, in the investigator’s judgment
- •3. Use of contraceptive measures
排除标准
- •1. Pregnant or breastfeeding, or intending to become pregnant during the study or within 85 days after the dose of RO7303509
- •2. No comorbid conditions that may interfere with the evaluation of an investigational medical product
- •3. No history or evidence of substance abuse that would pose a risk to participants safety, interfere with the conduct of the study, or have an impact on the study results
- •4. History of severe allergic or anaphylactic reactions to human, humanized, or Current treatment with medications that are well known to prolong the QT
研究者
相似试验
已完成
1 期
A study to test the effect of experimental drugs EDP1815 and EDP2939 on skin inflammation in healthy volunteers after KLH and imiquimod challengeKLH and imiquimod induced skin inflammation in healthy volunteersSkin and Connective Tissue DiseasesISRCTN29254828Evelo Biosciences38
已完成
1 期
A study to evaluate the safety, tolerability and processing by the body of RO7440688 in healthy volunteersCardiovascular diseaseISRCTN15492429Genentech, Inc67
已完成
3 期
A study to evaluate if different doses of KVD900 are safe and effective in treating attacks in patients with hereditary angioedemaHereditary angioedema (HAE) type I or type II.Haematological DisordersHereditary Angioedema Type I or IIISRCTN14762022KalVista Pharmaceuticals Ltd136
已完成
不适用
Dietary food supplement Helinorm containing L.reuteri DSM 17648 in eradication treatment inH.pylori-positive patients with functional dyspepsia?onfirmed diagnosis of functional dyspepsia according to Rome IV criteria and presence of H. pylori infection according to 13C-UBTDigestive SystemFunctional dyspepsiaISRCTN20716052izhny Novgorod Chemical and Pharmaceutical Plant Joint Stock Company (Nizhpharm JSC)172
已完成
1 期
Testing the safety and effects of a new drug (G3215) in adult subjectsDiabetes Mellitus ObesityNutritional, Metabolic, EndocrineISRCTN67889041Imperial College London24